Creative Financial Designs’s PDS Biotechnology PDSB Stock Holding History

Creative Financial Designs’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.64K	Hold	3,000	–	–	﹤0.01%	1854
2026 Q1	$1.81K	Hold	3,000	–	–	﹤0.01%	1792
2025 Q4	$2.31K	Hold	3,000	–	–	﹤0.01%	1662
2025 Q3	$3.03K	Hold	3,000	–	–	﹤0.01%	1636
2025 Q2	$3.99K	Hold	3,000	–	–	﹤0.01%	1565
2025 Q1	$3.57K	Hold	3,000	–	–	﹤0.01%	1557
2024 Q4	$4.89K	Buy	3,000 +950	+46%	+$2.51K	﹤0.01%	1427
2024 Q3	$7.83K	Hold	2,050	–	–	﹤0.01%	1264
2024 Q2	$6.01K	Buy	+2,050	New	+$6.56K	﹤0.01%	1284

Other funds holding PDSB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Creative Financial Designs's PDSB Position: Q2 2026 in Review

Creative Financial Designs held its PDS Biotechnology (PDSB) position steady in Q2 2026 at 3,000 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1854.

Creative Financial Designs first reported a position in PDSB in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.83K in Q3 2024. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

Creative Financial Designs held 3,000 shares of PDS Biotechnology worth $2.64K as of Q2 2026.
Creative Financial Designs left its PDS Biotechnology share count unchanged in Q2 2026.
PDS Biotechnology made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1854 holding.
Creative Financial Designs first reported a position in PDS Biotechnology in Q2 2024 and has held it in 9 quarters since.
Creative Financial Designs's PDS Biotechnology position peaked at $7.83K in Q3 2024.
52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.